ROYAL BANK OF CANADA – Vertex Pharmaceuticals Incorporated Transaction History
ROYAL BANK OF CANADA portfolio value:
$267.31M
portfolio value
ROYAL BANK OF CANADA quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +4.29% | 38.00K shares | 17.86M | $289.54 | 923.24K |
Q2 2022 | share | Increase | +5.37% | 45.14K shares | 30.21M | $281.79 | 885.23K |
Q1 2022 | share | Increase | +19.38% | 136.39K shares | 64.70M | $260.97 | 840.09K |
Q4 2021 | share | Decrease | -9.85% | -76.89K shares | 12.94M | $222.45 | 703.69K |
Q3 2021 | share | Decrease | -27.19% | -291.55K shares | -74.58M | $181.39 | 780.59K |
Q2 2021 | share | Increase | +27.40% | 230.56K shares | 35.32M | $201.63 | 1.07M |
Q1 2021 | share | Decrease | -4.03% | -35.37K shares | -26.41M | $214.89 | 841.57K |
Q4 2020 | share | Increase | +20.14% | 147.02K shares | 8.62M | $236.34 | 876.94K |
Q3 2020 | share | Increase | +25.12% | 146.55K shares | 29.26M | $272.12 | 729.92K |
Q2 2020 | share | Increase | +9.44% | 50.29K shares | 42.51M | $290.31 | 583.37K |
Q1 2020 | share | Decrease | -17.56% | -113.54K shares | -14.73M | $237.95 | 533.07K |
Q1 2020 | call | Decrease | -100.00% | -170K shares | -37.22M | $237.95 | 0 |
Q4 2019 | share | Increase | +5.98% | 36.45K shares | 38.20M | $218.95 | 646.62K |
Q4 2019 | call | Increase | 0.00% | 170K shares | 37.22M | $218.95 | 170K |
Q3 2019 | share | Increase | +18.15% | 93.73K shares | 8.67M | $169.42 | 610.16K |
Q3 2019 | call | Decrease | -100.00% | -257.9K shares | -47.29M | $169.42 | 0 |
Q2 2019 | call | Increase | 0.00% | 257.9K shares | 47.29M | $183.38 | 257.9K |
Q2 2019 | share | Increase | +0.91% | 4.63K shares | 558K | $183.38 | 516.43K |
Q1 2019 | share | Decrease | -19.22% | -121.74K shares | -10.84M | $183.95 | 511.79K |
Q4 2018 | share | Increase | +11.44% | 65.05K shares | -4.13M | $165.71 | 633.54K |
Q4 2018 | call | Decrease | -100.00% | -200.4K shares | -38.62M | $165.71 | 0 |
Q3 2018 | call | Increase | 0.00% | 200.4K shares | 38.62M | $192.74 | 200.4K |
Q3 2018 | share | Increase | +14.43% | 71.70K shares | 24.68M | $192.74 | 568.48K |
Q2 2018 | share | Decrease | -12.44% | -70.56K shares | -8.03M | $169.96 | 496.78K |
Q1 2018 | share | Increase | +69.27% | 232.18K shares | 42.23M | $162.98 | 567.34K |
Q4 2017 | share | Increase | +105.00% | 171.67K shares | 25.37M | $149.86 | 335.16K |
Q3 2017 | share | Increase | +15.16% | 21.52K shares | 6.56M | $152.04 | 163.49K |
Q2 2017 | share | Increase | +67.43% | 57.17K shares | 9.02M | $128.87 | 141.97K |
Q1 2017 | share | Decrease | -26.72% | -30.92K shares | 746K | $109.35 | 84.79K |
Q1 2017 | put | Decrease | -100.00% | -20K shares | -1.47M | $109.35 | 0 |
Q4 2016 | share | Decrease | -27.78% | -44.51K shares | -5.44M | $73.67 | 115.71K |
Q4 2016 | put | 0.00% | 0 shares | -271K | $73.67 | 20K | |
Q3 2016 | put | Decrease | -60.00% | -30K shares | -2.55M | $87.21 | 20K |
Q3 2016 | share | Increase | +21.76% | 28.63K shares | 2.65M | $87.21 | 160.22K |
Q2 2016 | share | Increase | +5.72% | 7.11K shares | 1.42M | $86.02 | 131.59K |
Q2 2016 | put | Decrease | -16.67% | -10K shares | -468K | $86.02 | 50K |
Q1 2016 | put | Increase | +184.36% | 38.9K shares | 2.11M | $79.49 | 60K |
Q1 2016 | share | Increase | +0.99% | 1.21K shares | -5.61M | $79.49 | 124.47K |